Earning (Loss) Per Share |
Earnings (Loss) Per Share The following table is the basic and diluted earnings (loss) per share computation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
|
2024 |
2023 |
|
|
|
|
Numerator: |
|
|
|
|
|
|
Net income (loss) for basic earnings per share |
$ |
413,612 |
|
$ |
(14,138,665) |
|
|
|
|
|
Adjustments to net income (loss) available to shareholders |
|
|
|
|
|
|
Change in fair value of SPA warrant liabilities |
(7,942,330) |
|
- |
|
|
|
|
|
Adjusted net loss for diluted earnings per share |
$ |
(7,528,718) |
|
$ |
(14,138,665) |
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
Weighted average shares used to compute basic EPS |
44,635,720 |
39,765,361 |
|
|
|
|
Dilutive effect of: |
|
|
|
|
|
|
Restricted and performance stock units |
434,562 |
|
- |
|
|
|
|
|
SPA Warrants |
21,672,526 |
|
- |
|
|
|
|
|
Weighted average shares used to compute diluted EPS |
66,742,808 |
|
39,765,361 |
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share |
$ |
0.01 |
|
$ |
(0.36) |
|
|
|
|
|
Diluted loss per share |
$ |
(0.11) |
|
$ |
(0.36) |
|
|
|
|
|
|
|
|
|
|
|
|
Anti-dilutive securities excluded from shares outstanding: |
|
|
|
|
|
|
Stock options |
2,555,470 |
3,472,129 |
|
|
|
|
Restricted and performance stock units |
4,624,496 |
3,169,269 |
|
|
|
|
Warrants |
15,800,000 |
18,722,425 |
|
|
|
|
Earnout shares |
7,499,993 |
7,499,993 |
|
|
|
|
Convertible debt |
119,192,018 |
2,922,425 |
|
|
|
|
Total |
149,671,977 |
35,786,241 |
|
|
|
|
|